phosphorylcholine has been researched along with celecoxib in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Elrod, HA; Khuri, FR; Sun, SY; Yue, P | 1 |
Cui, S; Ge, RL; Ji, L; Li, Z; Ma, J; Zhao, C | 1 |
2 other study(ies) available for phosphorylcholine and celecoxib
Article | Year |
---|---|
Celecoxib antagonizes perifosine's anticancer activity involving a cyclooxygenase-2-dependent mechanism.
Topics: Antineoplastic Agents; Base Sequence; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Celecoxib; Cell Line, Tumor; Cyclooxygenase 2; Drug Screening Assays, Antitumor; Enzyme-Linked Immunosorbent Assay; Gene Silencing; Humans; Immunohistochemistry; Lung Neoplasms; Phosphorylcholine; Pyrazoles; RNA, Small Interfering; Sulfonamides | 2009 |
PI3K-Akt Signal Transduction Molecules Maybe Involved in Downregulation of Erythroblasts Apoptosis and Perifosine Increased Its Apoptosis in Chronic Mountain Sickness.
Topics: Adult; Altitude Sickness; Apoptosis; bcl-X Protein; Bone Marrow Cells; Caspase 9; Celecoxib; China; Chronic Disease; Down-Regulation; Erythroblasts; Humans; Male; Middle Aged; Phosphatidylinositol 3-Kinases; Phosphorylcholine; Primary Cell Culture; Proto-Oncogene Proteins c-akt; Signal Transduction | 2017 |